[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345680-105":59,"doc-detail-345680-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sequential-field-therapy-in-actinic-keratosis-a-mechanism-based-rationale-for-complementary-treatment-strategies","Sequential Field Therapy in Actinic Keratosis - A Mechanism-Based Rationale for Complementary Treatment Strategies","","Actinic keratoses are common precursor lesions arising in chronically ultraviolet-damaged skin and carry an elevated risk of progression to cutaneous squamous cell carcinoma. Field cancerization reframes management from isolated visible lesions to broader field-directed strategies encompassing both clinical and subclinical disease. This narrative review synthesizes rationale, mechanisms, efficacy, tolerability, and limitations of field-directed therapies including 5-fluorouracil, imiquimod, diclofenac, photodynamic therapy, and tirbanibulin.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sequential-field-therapy-in-actinic-keratosis-a-mechanism-based-rationale-for-complementary-treatment-strategies/345680/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sequential-field-therapy-in-actinic-keratosis-a-mechanism-based-rationale-for-complementary-treatment-strategies/345680.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is field cancerization and why does it change actinic keratosis treatment?","Question",{"text":112,"@type":113},"Field cancerization describes chronically sun-damaged skin containing genetically altered keratinocytes beyond visible lesions. It supports shifting from treating isolated lesions to field-directed approaches targeting clinical and subclinical disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which field-directed therapies are reviewed for actinic keratosis?",{"text":117,"@type":113},"The review summarizes therapies including 5-fluorouracil, imiquimod, diclofenac, photodynamic therapy, and tirbanibulin, focusing on their mechanisms, efficacy, tolerability, and practical limitations.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are sequential treatment strategies proposed?",{"text":121,"@type":113},"The authors propose sequencing because therapies act through partially non-overlapping mechanisms, such as cytotoxic activity, immune activation, COX-2 inhibition, photodynamic oxidative damage, and tubulin/Src pathway inhibition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345680,1790323422,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Review  \nSequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies  \nGiulio Gualdi 1, Gabriele Soligon 1, Patrick Silvetti 1, Leonardo Balestra 1, Davide Bertolla 1,2, *, Luca Fania 3,4, Francesco Ricci 3,4, Mario Puviani 5, Paolo Sbano 6 and Andrea Paradisi 7  \nReceived: 30 April 2026  \nRevised: 8 June 2026  \nAccepted: 9 June 2026  \nPublished: 11 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 University Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy; [giulio.gualdi@unipr.it](giulio.gualdi@unipr.it) (G.G.); [gabriele.soligon@unipr.it](gabriele.soligon@unipr.it) (G.S.); [patrick.silvetti@unipr.it](patrick.silvetti@unipr.it) (P.S.); [leonardo.balestra@unipr.it](leonardo.balestra@unipr.it) (L.B.)  \n2 Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy  \n3 Skin Cancer Center, Istituto Dermopatico dell’Immacolata-IRCCS, 00167 Rome, Italy  \n4 Department of Life Science, Health, and Health Professions, Link University of Rome, 00168 Rome, Italy  \n5 Dermatology Clinic, Sassuolo Hospital, 41049 Sassuolo, Italy  \n6 Dermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena,  \n53100 Siena, Italy  \n7 Dermatology Unit, Department of Medical, Surgical, Abdominal and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy  \n* Correspondence: [davide.bertolla@edu.unife.it](davide.bertolla@edu.unife.it); Tel.: +39-0532-239684; Fax: +39-0532-206791  \nAbstract  \nBackground: Actinic keratoses are common keratinocytic precursor lesions arising within chronically ultraviolet-damaged skin and are associated with an increased risk of progression to cutaneous squamous cell carcinoma. The concept of field cancerization has shifted therapeutic strategies from the treatment of isolated visible lesions toward broader field-directed approaches targeting both clinical and subclinical disease. Methods: This narrative review summarizes the rationale, mechanisms of action, efficacy profile, tolerability, and practical limitations of currently available field-directed therapies for actinic keratosis, including 5-fluorouracil, imiquimod, diclofenac, photodynamic therapy, and tirbanibulin. Based on their distinct biological targets, we propose a mechanism-based framework for sequential treatment strategies. Results: Available therapies act through partially non-overlapping mechanisms, including cytotoxic activity, immune activation, cyclooxygenase-2 inhibition, photodynamic oxidative damage, and tubulin/Src pathway inhibition. These complementary effects provide a biological rationale for sequential regimens aimed at addressing the heterogeneity of field cancerization. However, direct clinical evidence supporting specific treatment sequences remains limited, and proposed regimens should be interpreted as hypothesis-generating rather than as validated therapeutic protocols. Conclusions: Mechanism-based sequential field therapy may represent a rational strategy to optimize long-term control of actinic keratosis and field cancerization. Prospective comparative studies are needed to define optimal sequences, treatment intervals, patient selection criteria, and clinically meaningful endpoints, including sustained field clearance, recurrence reduction, tolerability, adherence, and prevention of progression to invasive cutaneous squamous cell carcinoma.  \nKeywords: actinic keratosis; field cancerization; sequential treatment; tirbanibulin; 5-fluorouracil; diclofenac; imiquimod; photodynamic therapy  \n1. Introduction  \nActinic keratosis (AK) is a common keratinocytic lesion caused by chronic ultraviolet (UV) radiation and is recognized as a precursor to invasive cutaneous squamous c","cbCainYAZ5eCzIhx","https://ap.wps.com/l/cbCainYAZ5eCzIhx","pdf",299347,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Field-Directed Therapies\n## Topical 5-Fluorouracil","[{\"question\":\"What is field cancerization and why does it change actinic keratosis treatment?\",\"answer\":\"Field cancerization describes chronically sun-damaged skin containing genetically altered keratinocytes beyond visible lesions. It supports shifting from treating isolated lesions to field-directed approaches targeting clinical and subclinical disease.\"},{\"question\":\"Which field-directed therapies are reviewed for actinic keratosis?\",\"answer\":\"The review summarizes therapies including 5-fluorouracil, imiquimod, diclofenac, photodynamic therapy, and tirbanibulin, focusing on their mechanisms, efficacy, tolerability, and practical limitations.\"},{\"question\":\"Why are sequential treatment strategies proposed?\",\"answer\":\"The authors propose sequencing because therapies act through partially non-overlapping mechanisms, such as cytotoxic activity, immune activation, COX-2 inhibition, photodynamic oxidative damage, and tubulin/Src pathway inhibition.\"}]","Sequential Field Therapy in Actinic Keratosis - A Mechanism-Based Rationale for Complementary Treatment Strategies | PDF",1790058580,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68d7d1df9d642045231136a9ad5a0457.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/533d0a1c226b6062f7846ba78b1fdf04.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f590b69d9b98550e9a48d4771113c903.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b3b9dd3714f557e912f971b98e538c1.webp",980,1385]